NTES [NetEase] 6-K: (Original Filing)

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Fourth Quarter and Fiscal Year 2014 Unaudited Financial Results (Beijing — February 9, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:26:03+00:00 February 10th, 2015|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: Contact for Media and Investors: Cassia Curran NetEase,

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Fourth Quarter and Fiscal Year 2014 Unaudited Financial Results (Beijing — February 9, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:27:17+00:00 February 10th, 2015|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

XRS [TAL Education] SC 13G/A: (Original Filing)

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

By | 2016-03-27T00:04:32+00:00 February 10th, 2015|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] SC 13G/A: * The remainder of this cover page shall

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

By | 2016-03-27T00:05:28+00:00 February 10th, 2015|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] SC 13G: (Original Filing)

[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to the liabilities of that section of the Act but shall be]

By | 2016-03-27T00:06:48+00:00 February 10th, 2015|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] SC 13G: filing on this form with respect to the

[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to the liabilities of that section of the Act but shall be]

By | 2016-03-27T00:08:17+00:00 February 10th, 2015|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D: THIS DEED OF SETTLEMENT is made the 15

[THIS DEED OF SETTLEMENT is made the 15 th day of December 2014 between: 1. China Cord Blood Corporation, a company incorporated in the Cayman Islands with limited liability (Company Registration No. CT-227732) and whose shares are listed on the NYSE (hereinafter referred to as “the Settlor”) of the one part; and 2. Magnum Opus International (PTC) Limited, a company] [To: The Directors of China Cord Blood Corporation (the “Company”) Dear Sirs, Application for Shares We apply for and request you to allot and issue to us 7,080,000 shares of the Company at par value of US$0.0001 each (the “Shares”). In consideration for the issue of the Shares, we hereby agree and undertake to pay on demand US$708 to the] []

By | 2016-03-27T09:26:00+00:00 February 10th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar